Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

132.92 -0.04 (-0.03%)
Official Closing Price Updated: 7:00 PM EDT, Jun 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,758,461
Open 133.12
Bid (Size) 127.31 (2)
Ask (Size) 132.70 (1)
Prev. Close 132.96
Today's Range 132.60 - 134.63
52wk Range 99.14 - 134.63
Shares Outstanding 2,531,374,696
Dividend Yield 2.20%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
From Merck & Co., Inc.
Via Business Wire
Analyst Sees Keros Therapeutics As Next Acceleron, Set For Major Biotech Growth
Keros Therapeutics is advancing novel therapies for hematological and cardiopulmonary disorders via TGF-β signaling regulation. Oppenheimer rates KROS Outperform with a $102 price target. 
Via Benzinga

Performance

YTD
+17.38%
+17.38%
1 Month
+5.42%
+5.42%
3 Month
+5.90%
+5.90%
6 Month
+23.50%
+23.50%
1 Year
+17.55%
+17.55%

More News

Read More
Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Merck & Co
Via Benzinga
Competitor Analysis: Evaluating Merck & Co And Competitors In Pharmaceuticals Industry
Via Benzinga
Merck & Co Unusual Options Activity For June 14
Via Benzinga
Forget Nvidia: Prominent Billionaires Are Selling It in Favor of These 7 Top-Notch Stocks
Via The Motley Fool
3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains
Via InvestorPlace
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
Via Benzinga
AbbVie Inc. Dividend Stock Analysis - Saturday, June 22
Via Talk Markets
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
Via Benzinga
How Is The Market Feeling About Merck & Co?
Via Benzinga
3 Top Penny Stocks to Skyrocket Your Wealth in 2024
Via InvestorPlace
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
Via FinancialNewsMedia
Topics Death
Exposures Death
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Via Benzinga
Exposures COVID-19
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
From FN Media Group LLC
Via GlobeNewswire
FDA Approves Merck's Pneumococcal Vaccine As First Shot Designed For Adults
Via Benzinga
Exposures Product Safety
U.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults
From Merck & Co., Inc.
Via Business Wire
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients With Primary Advanced or Recurrent Endometrial Carcinoma
From Merck & Co., Inc.
Via Business Wire
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines
Via MarketBeat
Exposures COVID-19
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
Via The Motley Fool
3 Crazy Good Stocks to Buy With $500 Right Now
Via InvestorPlace
3 Penny Stocks to Buy if You Want to Spend Less and Earn More
Via InvestorPlace
3 High-Yield Dividend Stocks to Collect Impressive Payouts Year After Year
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.